Cutler Group’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-4,760
| Closed | -$87K | – | 2332 |
|
|
2022
Q4 | $87K | Buy |
+4,760
| New | +$87K | 0.01% | 660 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 2567 |
|
|
2022
Q2 | – | Sell |
-8,530
| Closed | -$166K | – | 2580 |
|
|
2022
Q1 | $166K | Buy |
8,530
+7,604
| +821% | +$148K | 0.01% | 646 |
|
|
2021
Q4 | $15K | Buy |
+926
| New | +$15K | ﹤0.01% | 1568 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 2782 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 2490 |
|
|
2020
Q1 | – | Sell |
-1,300
| Closed | -$21K | – | 2178 |
|
|
2019
Q4 | $21K | Sell |
1,300
-100
| -7% | -$1.62K | ﹤0.01% | 1120 |
|
|
2019
Q3 | $18K | Hold |
1,400
| – | – | ﹤0.01% | 1085 |
|
|
2019
Q2 | $18K | Hold |
1,400
| – | – | ﹤0.01% | 1182 |
|
|
2019
Q1 | $22K | Hold |
1,400
| – | – | ﹤0.01% | 1039 |
|
|
2018
Q4 | $28K | Sell |
1,400
-500
| -26% | -$10K | ﹤0.01% | 999 |
|
|
2018
Q3 | $47K | Buy |
1,900
+200
| +12% | +$4.95K | ﹤0.01% | 951 |
|
|
2018
Q2 | $46K | Buy |
1,700
+600
| +55% | +$16.2K | ﹤0.01% | 918 |
|
|
2018
Q1 | $33K | Sell |
1,100
-1,500
| -58% | -$45K | ﹤0.01% | 1066 |
|
|
2017
Q4 | $92K | Buy |
2,600
+2,000
| +333% | +$70.8K | ﹤0.01% | 880 |
|
|
2017
Q3 | $16K | Sell |
600
-1,616
| -73% | -$43.1K | ﹤0.01% | 1722 |
|
|
2017
Q2 | $58K | Sell |
2,216
-5,074
| -70% | -$133K | ﹤0.01% | 1416 |
|
|
2017
Q1 | $151K | Sell |
7,290
-800
| -10% | -$16.6K | 0.01% | 954 |
|
|
2016
Q4 | $167K | Sell |
8,090
-4,400
| -35% | -$90.8K | 0.01% | 933 |
|
|
2016
Q3 | $202K | Buy |
12,490
+6,144
| +97% | +$99.4K | 0.01% | 768 |
|
|
2016
Q2 | $86K | Sell |
6,346
-1,208
| -16% | -$16.4K | ﹤0.01% | 1093 |
|
|
2016
Q1 | $131K | Buy |
7,554
+800
| +12% | +$13.9K | 0.01% | 792 |
|
|
2015
Q4 | $230K | Buy |
+6,754
| New | +$230K | 0.01% | 638 |
|